Tenax Therapeutics is trading 5.4% up at $2.04, based on live price context; no September 8, 2026 company-specific announcement explicitly explains the move.
- Recent investor attention may relate to analysis of a prespecified subgroup showing a 26.3-meter placebo-adjusted walking benefit, though the article did not connect the finding to the stock move.
- The company is scheduled to present at the Cantor Global Healthcare Conference on September 9, 2026.